718
R. Arienzo, J. D. Kilburn / Tetrahedron 58 (2002) 711±719
(29 mL, 0.166 mmol), and the resulting suspension was
shaken for 20 h. A solution of acid 5 (220 mg, 0.417
mmol), PyBOP (217 mg, 0.417 mmol), HOBt (56.3 mg,
0.417 mmol) in DMF (2 mL) was added to the resin,
followed by DIPEA (303 mL, 1.74 mmol) and the suspen-
sion was shaken for 20 h. Any remaining amine residues
were capped by treating the reisn with an excess of acetic
anhydride. The resin was ®ltered and washed with CH2Cl2
(3£5 mL), DMF (3£5 mL), CH2Cl2 (3£5 mL). A qualitative
ninhydrin test was negative. Subsequent Boc deprotection
was achieved with a solution of TFA (30%) in DCM for 2 h.
The resin was washed with CH2Cl2 (3£5 mL), DMF
(3£5 mL), CH2Cl2 (3£5 mL) and washed with a solution
of DIPEA (10%) in DCM, MeOH (3£5 mL) and Et2O
(5£5 mL) and dried in vacuo. The tweezer library was
then prepared, using three cycles of split and mix synthesis.
Thus the resulting resin was divided in 12 equal portions. To
each resin portion one of the following Fmoc amino acids
was added: l-Ala, l-Gln, l-Glu(OtBu), Gly, l-Leu,
l-Lys(Boc), l-Met, l-Phe, l-Pro, l-Ser(tBu), l-Trp, l-Val
(0.08 mmol amino acid per resin portion), along with HBTU
(30 mg, 0.08 mmol) and DIPEA (47 mL, 0.27 mmol) in
DMF (2 mL). The reaction mixtures were shaken for 18 h.
Qualitative ninhydrin test were carried out to check all
transformations were complete. The resin was mixed and
the terminal Fmoc-groups removed with 20% piperidine in
DMF. The resin was split again into 12 equal portions and
the procedure repeated twice in order to build up the tweezer
receptor library 7.
and the resulting mixture was stirred for 2 h. The solution
was concentrated and the trituration of the resulting oil with
diethyl ether gave the bis-TFA salt as a white solid, which
was dissolved in DMF (2 mL). Boc±Val (0.12 g, 0.55
mmol), HBTU (0.21 g, 0.55 mmol) and DIPEA (0.16 mL,
0.93 mmol) were added and the resulting mixture stirred for
18 h. The precipitate formed was isolated by centrifugation
to give the diamidopyridine 12 as a white solid (0.14 g,
1
73%). Analytical data: mp decompose .2108C; H NMR
(400 MHz, [D6] DMSO) d10.04 (s, 2H, NHCO), 7.96 (br
s, 2H, br CH2CH2NHCO), 7.82 (d, J7 Hz, 2H, CHNHCO),
7.42±7.32 (m, 7H, ArH1pyrH), 7.19 (s, 2H, CONHaHb),
6.74 (m, 4H, NHBoc1CONHaHb), 5.21 (s, 2H, CH2Ar),
4.89 (s, 2H, OCH2CO), 4.22 (br s, 2H, CHCH(CH3)2),
3.79 (br s, 2H, CHCH2CH2CONH2), 3.3 (m, 4H,
NHCOCH2CH2), 2.57 (m, 4H, NHCOCH2.CH2), 2.05 (m,
4H, CH2CONH2), 1.94 (m, 2H, CH(CH3)2), 1.82 (m, 2H,
CHaHbCH2CONH2), 1.72 (m, 2H, CHaHbCH2CONH2), 1.38
(s, 18H, C(CH3)3), 0.82 (d, J6.5 Hz, 6H, CH(CH3)2), 0.8
(d, J6.5 Hz, 6H, CH(CH3)2); 13C NMR (100 MHz, [D6]
DMSO) d173.7(0), 171.2(0), 170.6(0), 168.0(0),
166.4(0), 162.4(0), 155.6(0), 151.4(0), 135.6(0), 128.5(1),
128.2(1), 128.1(1), 95.7(1), 78.2(0), 64.7(2), 62.9(2),
57.1(1), 51.8(1), 35.6(2), 34.3(2), 31.0(2), 30.3(1),
30.1(2), 28.2(3), 19.3(3), 18.1(3); MS (ES1): m/z (%)
1070.1 (100) [M1H]1, 1091.9 (40) [M1Na]1.
6.1.6. Benzyl 2-{3,5-di[(3-{[5-amino-2-({2-[(5-amino-2-
{[(9H-9-¯uorenylmethoxy)carbonyl]amino}-5-oxopenta-
noyl)amino]-3-methylbutanoyl}amino)-5-oxopentanoyl]-
amino}propanoyl)amino]phenoxy}acetate (13). TFA
(1 mL) was added dropwise to a solution of the diamido-
pyridine 12 (0.08 g, 0.075 mmol) in CH2Cl2 (3 mL) and the
resulting mixture was stirred for 2 h. The solution was
concentrated and the trituration of the resulting oil with
diethyl ether gave the bis-TFA salt as a white solid, which
was dissolved in DMF (2 mL). Fmoc±Gln (0.06 g, 0.16
mmol), HBTU (0.06 g, 0.16 mmol) and DIPEA (0.05 mL,
0.3 mmol) were added and the resulting mixture stirred for
18 h. The precipitate formed was isolated by centrifugation
to give the diamidopyridine 13 as a white solid (0.08 g,
6.1.4. Benzyl 2-(3,5-di{[3-({5-amino-2-[tert-butoxycarbo-
nyl)amino]-5-oxopentanoyl}amino)propanoyl]amino}-
phenoxy)acetate (11). TFA (2 mL) was added dropwise to
a solution of the diamidopyridine 4 (0.16 g, 0.26 mmol) in
CH2Cl2 (4 mL) and the resulting mixture was stirred for 2 h.
The solution was concentrated and the trituration of the
resulting oil with diethyl ether gave the bis TFA salt as a
white solid, which was dissolved in DMF (2 mL). Boc±Gln
(0.196 g, 0.76 mmol), HBTU (0.3 g, 0.76mmol) and DIPEA
(0.23 mL, 1.32 mmol) were added and the resulting mixture
stirred for 18 h. The precipitate formed was isolated by
centrifugation to give the diamidopyridine 11 as a white
solid (0.16 g, 70%). Analytical data: mp .2408C; 1H
NMR (400 MHz, [D6] DMSO) d10.05 (s, 2H, NHpyr),
7.82 (br s, 2H, NHCH2CH2), 7.41±7.31 (m, 7H, ArH1
pyrH), 7.22 (s, 2H, CONHaHb), 6.82 (d, J7.5 Hz, 2H,
NHBoc), 6.72 (s, 2H, CONHaHb), 5.21 (s, 2H, CH2Ar),
4.88 (s, 2H, OCH2CO), 3.84 (m, 2H, CHNHBoc), 3.38
(m, 4H, CH2CH2NH), 2.57 (m, 4H, CH2CH2NH), 2.07 (m,
4H, CH2CONH2), 1.81 (m, 2H, CHaHbCHNHBoc), 1.66 (m,
2H, CHaHbCHNHBoc), 1.35 (s, 18H, C(CH3)3). 13C NMR
(100 MHz, [D6] DMSO) d173.2(0), 171.2(0), 170.1(0),
167.36(0), 165.7(0), 154.7(0), 150.8(0), 134.9(0), 127.8(1),
127.6(1), 127.4(1), 95.1(1), 77.5(0), 65.7(2), 63.9(2),
54.3(2), 53.5(1), 35.6(2), 34.2(2), 31.03(2), 27.6(3).
LRMS (ES1): m/z (%)872.3 (80) [M1H]1, 894.3 (10)
[M1Na]1.
1
70%). Analytical data: mp decompose .2408C; H NMR
(400 MHz, 313 K, [D6] DMSO) d9.94 (s, 2H, pyrNH),
7.96 (d, J7.5 Hz, 2H, NH), 7.90 (d, 4H, J7.5 Hz,
¯uorenylH), 7.85 (t, J6 Hz, 2H, CH2CH2NHCO), 7.75±
7.70 (m, 6H, NH1¯uorenylH), 7.53 (d, 2H, NH), 7.45±7.32
(m, 15H, ArH1¯uorenylH1pyrH), 7.24 (s, 2H,
CONHaHb),7.16 (s, 2H, CONHcHd), 6.72 (s, 2H,
CONHaHb), 6.67 (s, 2H, CONHcHd), 5.10 (s, 2H,
OCH2Ph), 4.79 (s, 2H, OCH2CO), 4.16±4.07 (m, 10H,
CHCH(CH3)2, CHCH2CH2CONH2, CHCH2¯uorenyl), 3.94
(m, 2H, CHCH2CH2CONH2), 3.40 (m, 4H, CH2CH2NH),
2.20±1.70
(m,
14H,
CH2CH2NH1CH(CH3)21
CH2CH2CONH2), 0.85 (d, 6H, CH3), 0.83 (d, 6H,
CH3); 13C NMR (100 MHz, [D6] DMSO) d173.9(0),
173.7(0), 171.1(0), 170.7(0), 170.5(0), 167.9(0), 166.3(0),
157.3(0), 155.9(0), 151.3(0),143.8(0), 140.7(0), 135.5(0),
128.4(1), 128.1(1), 128.0(0), 127.6(0), 127.1(1), 125.3(1),
120.1(0), 95.7(1), 66.2(2), 65.7(2), 64.5(2), 57.5(1),
54.3(1), 52.3(1), 46.6(1), 36.1(2), 34.7(2), 31.6(2),
31.4(2), 30.5(1), 27.9(2), 27.7(2), 19.2(3), 17.8(3), MS
(TOF LD1): m/z (%) 1571.07 (100) [M1H]1, 3301.65
(30) [2M1H]1.
6.1.5. Benzyl 2-(3,5-di[(3-{[5-amino-2-({2-[(tert-butoxy-
carbonyl)amino]-3-methylbutanoyl}amino)-5-oxopenta-
noyl]amino}propanoyl)amino]phenoxy}acetate
(12).
TFA (2 mL) was added dropwise to a solution of the
diamidopyridine 2 (0.16 g, 0.18 mmol) in CH2Cl2 (4 mL)